세계의 임상 검사 시장 : 규모, 점유율 및 동향분석(유형별, 최종 용도별, 지역별), 부문별 예측(2025-2030년)

Clinical Laboratory Tests Market Growth & Trends:

The global clinical laboratory tests market size is estimated to reach USD 213.04 billion by 2030, registering a CAGR of 8.88% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the clinical laboratory tests market is attributable to the rising prevalence of target diseases. The use of clinical laboratory tests is on a rise owing to the use of tests in a wide variety of diagnostic purposes that primarily focus on patient health leading to evaluating and formulating proper diagnosis and treatment.

The global geriatric population is increasing and is considered as being the greatest risk factor for the development of conditions, such as cardiovascular diseases and kidney dysfunction. According to WHO, the population aged above 60 years is expected to be 1 in every 6 people by 2030, which accounts for an increase from 1 billion in 2020 to 1.4 billion by 2030. In addition, the number of people aged 80 and above is projected to double to over 1.5 billion by 2050, and people aged above 80 years are expected to triple and reach 426 Billion. Thus, the growing geriatric population is expected to be a high-impact rendering driver for this market over the forecast period.

The growing prevalence of target diseases, such as CVD and diabetes, is anticipated to boost the market over the forecast period. CVD is fatal and leading cause of death worldwide. Presence of high unmet medical needs pertaining to cardiovascular diseases and the subsequent rise in patient awareness are among factors expected to boost the demand for point-of-care lipid testing. According to WHO, in 2021, cardiovascular diseases have been leading cause of mortality and morbidity worldwide in the last three decades, 17.7 Billion people die every year due to cardiovascular diseases, which is 31% of all the deaths worldwide.

Furthermore, key players involved in developing and formulating clinical laboratory tests are focusing on collaborations and partnerships to develop novel tuberculosis therapeutics and to maintain their competitive position in the market. In addition, increasing adoption of laboratory automation systems is expected to boost the market over the forecast period. For instance, in January 2023[, BD launched a third-generation total laboratory automation system, which automates lab specimen processing for microbiology laboratories. Moreover, in January 2023, NovoPath LLC expanded its LIS solutions for oncology laboratories.

Clinical Laboratory Tests Market Report Highlights:

• Based on type, the HbA1c testing segment held the largest market share at 12.39% in 2024, driven primarily by the rising global prevalence of diabetes and cholesterol-related conditions.
• The HGB/HCT testing type segment is projected to grow at the fastest CAGR during the forecast period.
• By end-use, the central laboratories segment held the largest share of the market in 2024, primarily due to high test volumes and widespread market penetration.
• The primary clinics end-use segment is expected to register the fastest CAGR during the forecast period.
• North America clinical laboratory tests industry held the largest share of market in 2024 and is expected to maintain its dominant position.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. End Use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. End Use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Clinical Laboratory Tests Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Trends and Outlook
• 3.4. Market Dynamics
  • 3.4.1. Rising Prevalence of Chronic Diseases
  • 3.4.2. Technological Advancements
  • 3.4.3. Growing Geriatric Population
• 3.5. Market Restraint Analysis
  • 3.5.1. Regulatory Challenges and Ambiguity
• 3.6. Industry Analysis Tools
  • 3.6.1. Porter's Five Forces Analysis
  • 3.6.2. PESTEL Analysis
• 3.7. Market Opportunity Analysis
• 3.8. Market Emerging Statergies

Chapter 4. Clinical Laboratory Tests Market: Type Estimates & Trend Analysis

• 4.1. Clinical Laboratory Tests Market: Type Movement Analysis
• 4.2. Clinical Laboratory Tests Market Estimates and Forecast, by Type
• 4.3. Complete Blood Count
  • 4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.4. HGB/HCT tests
  • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Basic metabolic panel
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. BUN creatinine tests
  • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Electrolytes testing
  • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. HbA1c tests
  • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.9. Comprehensive metabolic panel tests
  • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.10. Liver panel tests
  • 4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10.2. Hepatitis
    • 4.10.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10.3. Bile duct obstruction
    • 4.10.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10.4. Liver Cirrhosis
    • 4.10.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10.5. Liver Cancer
    • 4.10.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10.6. Bone disease
    • 4.10.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10.7. Autoimmune disorders
    • 4.10.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10.8. Others
    • 4.10.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.11. Renal panel tests
  • 4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.12. Others
  • 4.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.13. Microbiology Market, 2018 - 2030 (USD Million)
  • 4.13.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.14. Pathogen Testing
  • 4.14.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Clinical Laboratory Tests Market: End Use Estimates & Trend Analysis

• 5.1. Clinical Laboratory Tests Market: End Use Movement Analysis
• 5.2. Clinical Laboratory Tests Market Estimates and Forecast, by End Use
• 5.3. Primary Clinics
  • 5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.2. Complete blood count
    • 5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.3. HGB/HCT tests
    • 5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.4. Basic metabolic panel
    • 5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.5. BUN creatinine tests
    • 5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.6. Electrolytes testing
    • 5.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.7. HbA1c tests
    • 5.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.8. Comprehensive metabolic panel tests
    • 5.3.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.9. Liver panel tests
    • 5.3.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.10. Renal panel tests
    • 5.3.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.11. Lipid panel tests
    • 5.3.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.12. Others
    • 5.3.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.4. Central Laboratories
  • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Complete blood count
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. HGB/HCT tests
    • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Basic metabolic panel
    • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.5. BUN creatinine tests
    • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.6. Electrolytes testing
    • 5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.7. HbA1c tests
    • 5.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.8. Comprehensive metabolic panel tests
    • 5.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.9. Liver panel tests
    • 5.4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.10. Renal panel tests
    • 5.4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.11. Lipid panel tests
    • 5.4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.12. Others
    • 5.4.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Clinical Laboratory Tests Market: Regional Estimates & Trend Analysis

• 6.1. Clinical Laboratory Tests Market Share By Region, 2024 & 2030
• 6.2. Regional Market Share Analysis, 2024 & 2030
• 6.3. Regional Market Dashboard
• 6.4. Global Regional Market Snapshot
• 6.5. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.6. North America
  • 6.6.1. North America Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.6.2. U.S.
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. U.S. Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.6.3. Canada
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Canada Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.6.4. Mexico
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. Mexico Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
• 6.7. Europe
  • 6.7.1. Europe Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.7.2. UK
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. UK Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.7.3. Germany
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. Germany Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.7.4. France
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Competitive Scenario
    • 6.7.4.3. Regulatory Framework
    • 6.7.4.4. France Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.7.5. Italy
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Competitive Scenario
    • 6.7.5.3. Regulatory Framework
    • 6.7.5.4. Italy Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.7.6. Spain
    • 6.7.6.1. Key Country Dynamics
    • 6.7.6.2. Competitive Scenario
    • 6.7.6.3. Regulatory Framework
    • 6.7.6.4. Spain Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.7.7. Denmark
    • 6.7.7.1. Key Country Dynamics
    • 6.7.7.2. Competitive Scenario
    • 6.7.7.3. Regulatory Framework
    • 6.7.7.4. Denmark Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.7.8. Sweden
    • 6.7.8.1. Key Country Dynamics
    • 6.7.8.2. Competitive Scenario
    • 6.7.8.3. Regulatory Framework
    • 6.7.8.4. Sweden Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.7.9. Norway
    • 6.7.9.1. Key Country Dynamics
    • 6.7.9.2. Competitive Scenario
    • 6.7.9.3. Regulatory Framework
    • 6.7.9.4. Norway Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
• 6.8. Asia Pacific
  • 6.8.1. Asia Pacific Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.8.2. Japan
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Competitive Scenario
    • 6.8.2.3. Regulatory Framework
    • 6.8.2.4. Japan Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.8.3. China
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Competitive Scenario
    • 6.8.3.3. Regulatory Framework
    • 6.8.3.4. China Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.8.4. India
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Competitive Scenario
    • 6.8.4.3. Regulatory Framework
    • 6.8.4.4. India Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.8.5. Australia
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Competitive Scenario
    • 6.8.5.3. Regulatory Framework
    • 6.8.5.4. Australia Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.8.6. Thailand
    • 6.8.6.1. Key Country Dynamics
    • 6.8.6.2. Competitive Scenario
    • 6.8.6.3. Regulatory Framework
    • 6.8.6.4. Thailand Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.8.7. South Korea
    • 6.8.7.1. Key Country Dynamics
    • 6.8.7.2. Competitive Scenario
    • 6.8.7.3. Regulatory Framework
    • 6.8.7.4. South Korea Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
• 6.9. Latin America
  • 6.9.1. Latin America Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.9.2. Brazil
    • 6.9.2.1. Key Country Dynamics
    • 6.9.2.2. Competitive Scenario
    • 6.9.2.3. Regulatory Framework
    • 6.9.2.4. Brazil Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.9.3. Argentina
    • 6.9.3.1. Key Country Dynamics
    • 6.9.3.2. Competitive Scenario
    • 6.9.3.3. Regulatory Framework
    • 6.9.3.4. Argentina Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
• 6.10. MEA
  • 6.10.1. MEA Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.10.2. South Africa
    • 6.10.2.1. Key Country Dynamics
    • 6.10.2.2. Competitive Scenario
    • 6.10.2.3. Regulatory Framework
    • 6.10.2.4. South Africa Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.10.3. Saudi Arabia
    • 6.10.3.1. Key Country Dynamics
    • 6.10.3.2. Competitive Scenario
    • 6.10.3.3. Regulatory Framework
    • 6.10.3.4. Saudi Arabia Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.10.4. UAE
    • 6.10.4.1. Key Country Dynamics
    • 6.10.4.2. Competitive Scenario
    • 6.10.4.3. Regulatory Framework
    • 6.10.4.4. UAE Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
  • 6.10.5. Kuwait
    • 6.10.5.1. Key Country Dynamics
    • 6.10.5.2. Competitive Scenario
    • 6.10.5.3. Regulatory Framework
    • 6.10.5.4. Kuwait Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company Categorization
• 7.3. Strategy Mapping
• 7.4. Company Market Share Analysis, 2024
• 7.5. Company Profiles
  • 7.5.1. Quest Diagnostics Incorporated.
    • 7.5.1.1. Overview
    • 7.5.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.5.1.3. Product Benchmarking
    • 7.5.1.4. Strategic Initiatives
  • 7.5.2. Abbott
    • 7.5.2.1. Overview
    • 7.5.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.5.2.3. Product Benchmarking
    • 7.5.2.4. Strategic Initiatives
  • 7.5.3. Cinven
    • 7.5.3.1. Overview
    • 7.5.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.5.3.3. Product Benchmarking
    • 7.5.3.4. Strategic Initiatives
  • 7.5.4. Laboratory Corporation of America Holdings
    • 7.5.4.1. Overview
    • 7.5.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.5.4.3. Product Benchmarking
    • 7.5.4.4. Strategic Initiatives
  • 7.5.5. ARUP Laboratories
    • 7.5.5.1. Overview
    • 7.5.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.5.5.3. Product Benchmarking
    • 7.5.5.4. Strategic Initiatives
  • 7.5.6. OPKO Health, Inc.
    • 7.5.6.1. Overview
    • 7.5.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.5.6.3. Product Benchmarking
    • 7.5.6.4. Strategic Initiatives
  • 7.5.7. UNILABS
    • 7.5.7.1. Overview
    • 7.5.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.5.7.3. Product Benchmarking
    • 7.5.7.4. Strategic Initiatives
  • 7.5.8. Clinical Reference Laboratory, Inc.
    • 7.5.8.1. Overview
    • 7.5.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.5.8.3. Product Benchmarking
    • 7.5.8.4. Strategic Initiatives
  • 7.5.9. Synnovis Group LLP
    • 7.5.9.1. Overview
    • 7.5.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.5.9.3. Product Benchmarking
    • 7.5.9.4. Strategic Initiatives
  • 7.5.10. Sonic Healthcare Limited.
    • 7.5.10.1. Overview
    • 7.5.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.5.10.3. Product Benchmarking
    • 7.5.10.4. Strategic Initiatives